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Abstract
Background: Patients with inherited dilated cardiomyopathy (DCM) frequently die with severe heart failure (HF) or die
suddenly with arrhythmias, although these symptoms are not always observed at birth. It remains unclear how and when
HF and arrhythmogenic changes develop in these DCM mutation carriers. In order to address this issue, properties of the
myocardium and underlying gene expressions were studied using a knock-in mouse model of human inherited DCM caused
by a deletion mutation DK210 in cardiac troponinT.
Methodology/Principal Findings: By 1 month, DCM mice had already enlarged hearts, but showed no symptoms of HF and
a much lower mortality than at 2 months or later. At around 2 months, some would die suddenly with no clear symptoms of
HF, whereas at 3 months, many of the survivors showed evident symptoms of HF. In isolated left ventricular myocardium
(LV) from 2 month-mice, spontaneous activity frequently occurred and action potential duration (APD) was prolonged.
Transient outward (Ito) and ultrarapid delayed rectifier K
+ (IKur) currents were significantly reduced in DCM myocytes.
Correspondingly, down-regulation of Kv4.2, Kv1.5 and KChIP2 was evident in mRNA and protein levels. In LVs at 3-months,
more frequent spontaneous activity, greater prolongation of APD and further down-regulation in above K
+ channels were
observed. At 1 month, in contrast, infrequent spontaneous activity and down-regulation of Kv4.2, but not Kv1.5 or KChIP2,
were observed.
Conclusions/Significance: Our results suggest that at least three steps of electrical remodeling occur in the hearts of DCM
model mice, and that the combined down-regulation of Kv4.2, Kv1.5 and KChIP2 prior to the onset of HF may play an
important role in the premature sudden death in this DCM model. DCM mice at 1 month or before, on the contrary, are
associated with low risk of death in spite of inborn disorder and enlarged heart.
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Introduction
Inherited dilated cardiomyopathy (DCM) is a progressive
disease characterized by an enlarged and weakened heart. It has
recently become clear that gene mutations in various cytoskeletal
and sarcomeric proteins that lead to weakness in the systems
involved in force production can contribute to the development of
DCM [1–6]. The cause of death among patients with DCM is
severe heart failure (HF) (,50%), where cardiac output is
substantially decreased. In addition, lethal arrhythmias often
occur before symptoms of HF are evident, resulting in sudden
death (SD) (30–40%) [2,7].
At present, it remains unclear how HF and arrhythmogenic
changes proceed in carriers of DCM mutations. In many cases,
they are asymptomatic until symptoms of HF, such as breathless-
ness or tiredness, manifest [2], despite the inborn weakness in force
production, indicating that their hearts are compensated until
some event drives them to HF. In addition, their myocardium
might be arrhythmogenic before or during development of HF,
although clear evidence is still lacking. In humans, systematic
investigation of the functional properties of the DCM heart has
been difficult because the data are confounded by many
background factors such as complication from other diseases,
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tors, etc. [8].
A variety of genetically modified mouse models that develop
characteristics of DCM have been created in recent years by
knockout, knockdown or overexpression of some specific genes [9–
15]. These models show variable phenotypes of arrhythmia, i.e.,
abnormal conduction, bradycardia, ventricular tachycardia and
ventricular fibrillation, long QT syndrome, or no reports of
arrhythmia, depending on their genetic modifications [9–17].
Although these models are potentially useful for investigation of
DCM, it is unclear which type of familial DCM they mimic,
because most of their genetic modifications are not seen in familial
DCM. To understand the mechanisms of arrhythmogenesis in
familial DCM, investigations with knock-in animal models based
on real human DCM mutation are particularly needed [14,17].
Mutations in the cardiac troponin T gene (TNNT2) are reported
in ,3% of DCM patients [3,6,18]. Among them, a deletion
mutation of K210 (DK210, also known as DK217) that decreases
Ca
2+ sensitivity in force development accounts for one-third of all
mutations found in TNNT2 [3,6,18]. This mutation is believed to
be a recurrent mutation in human DCM, probably because the
site is susceptible to deletion mutation [18]. Onset of HF
symptoms or occurrence of SD in these DCM patients with the
DK210 mutation is variable, ranging from 10 to 70 years of age.
Recently, a knock-in mouse model of DCM caused by the
DK210 mutation was created based on the human familial DCM
[14,19]. The mutant mice showed markedly enlarged hearts and
significantly lower Ca
2+ sensitivity in force generation than wild-
type (WT) mice. The developed force of acutely isolated papillary
muscles from the mutant and WT mice was similar because the
peak amplitude of the Ca
2+ transients in cardiomyocytes was
increased in mutant mice, suggesting that the decreased
contractility was compensated by an increase in the Ca
2+
transients [14]. In many cases, these mice appeared to die
suddenly with a t1/2 of 70 days. Telemetric ECG recording
showed Torsades de Pointes at their SD [14], suggesting that
arrhythmogenic changes may occur. This model thus appears to
resemble the phenotypes of human DCM [14,20–21].
The aim of this study was to clarify (1) when HF develops, and
(2) whether, and if so how, electrical remodeling occurs in the
DCM model mice with the DK210 mutation. We assessed
spontaneous activity in myocardium, action potential (AP)
configuration and ionic currents in isolated myocytes. In addition,
we carried out real-time RT-PCR and Western blot analysis for
ion channels and associated proteins potentially involved in the
functional changes seen in DCM. Our results indicate that
multiple types of progressive electrical remodeling occur at
different time points in the hearts of DCM model mice. Clear
symptoms of congestive HF are preceded by this electrical
remodeling.
Results
In vivo properties of DCM model mice at 1, 2 and 3
months
Because the mortality of DCM model mice abruptly changes at
around 1.5 months of age (Fig. 1A) [14], we compared in vivo
properties of DCM mice at 1, 2 and 3 month. DCM mice had
significantly enlarged hearts with average heart weight/body
weight (HW/BW) ratio of about twice the WT mice at 1 and 2
months (Fig. 1B) [14] and even at birth (WT: 0.6060.03% (n=7);
DCM: 0.9760.05% (n=9)). The enlargement became more
prominent at 3 months. To determine when HF develops in DCM
mice, lung weight/body weight (LW/BW) ratio and voluntary
exercise activity were determined because HF is defined as
inability of the heart to supply sufficient blood flow to meet the
body’s needs and is accompanied by symptoms such as shortness
of breath (dyspnea) and exercise intolerance. The LW/BW ratio,
indicative of lung edema, was similar between DCM and WT
mice until 2 months. In DCM mice that survived to 3 months of
age, average LW/BW ratio significantly increased (Fig. 1C).
Physical activity was measured using a voluntary running wheel
[22]. At 2 months, wheel-running activity of DCM mice was
comparable to WT mice. However, at 3 months, running activity
was significantly decreased in DCM mice, whereas the activity in
the WT remained constant (Fig. 1D). These data suggest that
congestive HF and resultant pulmonary edema start to develop in
DCM mice between 2 and 3 months.
Table 1 shows in vivo parameters of WT and DCM mice.
There were no significant differences in body weights between WT
and DCM mice during 1–3 months. ECG records were obtained
from anesthetized and conscious mice. Although heart rate (HR)
under anesthetized condition was significantly higher in DCM
than WT mice at 1 month, this is probably due to difference in
depth of anesthesia. In conscious mice, HR was similar between
WT and DCM mice at the same age. ECG recording of 2-month
mice showed prolongation of QRS and QT intervals in DCM
mice as reported previously [14,21], whereas the prolongations
were less marked at 1 month (Table 1). Telemetric ECG recording
of mice at 2 months showed Torsades des pointes at their death as
reported previously (n=3) [14]. Noninvasive ECG records were
obtained for 30 min from conscious mice of 2 months by
restricting free movement in an oval plastic dome with openings at
mouth and tail (see methods). This procedure increased stress of
mice to enhance propensity for arrhythmias and allowed us to
analyze many mice repeatedly. Premature ventricular complexes
(PVC) were recorded from 3 out of 6 DCM mice during the
30 min recording period, whereas none were recorded in WT
(n=5) (Fig. 1E). Alternating T-wave morphology (T-wave
alternans) was observed in 3 out of 6 DCM mice (1 mouse
showed both PVC and T wave alternans). PVC (3 mice) and T
wave alternans (2 mice) were also obtained in DCM mice at 3
months (n=5). In addition to the abnormality in ECG, DCM
mice at 3 months became highly sensitive to anesthesia: with 3-
month DCM mice, 4 out of 10 mice died from respiratory arrest
during anesthesia (20 mg/kg pentobarbital injection); whereas 2-
month mice or younger survived at this dose.
Ventricular spontaneous activity assessed by membrane
potential imaging and force monitoring in isolated
myocardium
Since DCM model mice show a high incidence of death
beginning around 1.5 months (Fig. 1A) [14], we initially monitored
optical AP signals in isolated cardiac muscles from 2-month mice
to determine what occurs in DCM myocardium (Fig. 2). The
myocardium from 2-month WT and DCM hearts was loaded with
di-4-ANEPPS, and AP signals were recorded from the endocardial
side using a confocal microscope/W-view system as described
previously [23] (Fig. 2A). In WT LV, AP signals were only elicited
in response to stimulation, whereas DCM LV exhibited a large
number of spontaneous APs (Fig. 2B). The DCM myocardium
exhibited both sporadic APs (APs developing at rest) and burst-
firing (APs developing during the repolarizing phase), in addition
to the stimulus-induced ones.
Spontaneous activities were also confirmed as spontaneous
contractions in papillary muscles from LV. The records in Fig. 2C-
a show typical isometric contractions of LV papillary muscle
elicited by stimulation at 0.5 Hz. The WT LV showed twitch
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contractions were observed between stimuli in the DCM LV.
Fig. 2C-b shows force records collected during and after a period
of stimulation at 3 Hz. The WT LV showed twitch contractions
upon stimulation, and infrequently contracted after the stimulation
was stopped. The DCM muscle also responded to the 3 Hz
Figure 1. In vivo data of DCM mice. A. Kaplan-Meier survival curves for DCM mice (n=211) and their % death in our laboratory. B&C . HW/BW
ratio (B) and LW/BW ratio (C) in WT (n=5–7) and DCM mice (n=7 for 1 and 2 months; n=14 for 3 months). **P,0.01 between WT and DCM. D.
Average wheel running activity of WT and DCM mice at 2 and 3 months. Data at 2 and 3 months were obtained from the same animals (n=7).
*P,0.05 between 2 and 3 months. E. A typical normal ECG trace in WT (a) and representative traces of PVCs (b, c) and T-wave alternans (d) obtained
in conscious DCM mice at 2 months. Arrows in b and c indicate premature ventricular contractions (PVCs) occurred before atrioventricular
conduction. Dots and arrowheads in d indicate beat-to-beat alteration in T-waves.
doi:10.1371/journal.pone.0035353.g001
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after the stimulation period ended. Spontaneous contractions were
much more frequent in DCM LV (Fig. 2D). Similar measurements
were carried out with right ventricle (RV) and left atrial (LA)
muscles. Spontaneous activities were rarely observed in RV
(Fig. 2D) and LA (not shown) from both WT and DCM mice.
Myocardial automaticity appears to be considerably enhanced in
LVs.
Prolongation of AP duration (APD) in DCM LVs
Another notable change in the AP signals from DCM LVs was
an obvious lengthening of APD (Fig. 2E). Because ventricular APD
is known to be spatially different and is longer in the basal region
than the apical region of endocardium [24], APD was measured in
both regions in LV (Fig. 2F, left 4 columns). APD50 values (APD at
50% repolarization) were used because they are relatively stable
compared to longer APD measurements (e.g., APD80); APD80
measurements are more variable as they depend on the amount of
Na
+-Ca
2+ exchange (NCX) activity and they often suffer from
movement artifacts. In the basal region of WT mice, the average
APD50 was approximately 20 ms, which was comparable to
previous reports obtained from Langendorf-perfused mouse heart
using monophasic action potential recording [25–26]. APD50 in
DCM LVs was about 2-fold longer than that in WT LVs. In the
apical region, the APD50 from DCM mice was about 1.6-fold
longer than that from WT mice. In DCM RV, APD50 taken from
center region was also significantly prolonged in DCM compared
to WT, however, the absolute value was much shorter than in LV
(Fig. 2F, right 2 columns). Thus, APD was significantly prolonged
in DCM ventricle with the spatial difference tending to be
increased. The prolongation of APD is consistent with the
prolonged QT interval in DCM mice (Table 1). In the following
experiments, we mainly investigated properties of LVs from WT
and DCM mice.
AP and current recording by whole-cell clamp
In Fig. 3, we conducted whole-cell clamp experiments to further
examine the DCM-associated AP prolongation found in the
preceding optical measurement. For this purpose, single LV cells
from DCM and WT mice were whole-cell clamped in physiolog-
ical conditions at 37uC. Current-clamped DCM cells had a resting
membrane potential of 275.060.4 mV (n=16), which was
statistically indistinguishable from the value of WT cells
(276.160.5 mV, n=12).
Electrical stimulation (5 Hz) evoked APs having a spike-and-
dome configuration in both cells (Fig. 3A-a). The spike was much
broader in DCM cells than in WT cells due to a reduced rate of
early-phase repolarization; accordingly, the APD50 of DCM cells
was ,3 times as large as that of WT cells (Fig. 3A-b). Terminal
repolarization of the AP was more variable in both WT and
DCM; accordingly, the APD80 of DCM cells was 10% larger than
in WT cells but without statistical significance. These findings on
AP prolongation are consistent with the preceding optical
measurements (Fig. 2B, E, F).
We then explored alterations in the membrane current systems
that underlie the DCM-associated APD prolongation. For this
purpose, the cells were voltage-clamped at a holding potential of
278 mV, and whole-cell current was activated by 1 s square
pulses. As illustrated in Fig. 3B-a, the outward whole-cell current
activated by depolarizing pulses had a smaller amplitude in DCM
cells than in WT cells, supporting the slower AP repolarization
observed in DCM cells. In contrast, the inward current activated
by hyperpolarizing pulses, which is mostly attributable to the
inward-rectifier K
+-current (IK1), in DCM cells had a comparative
amplitude to WT cells (Fig. 3B-b).
Table 1. Summary of in vivo parameters.
Age 1 month 2 months 3 months
WT DCM WT DCM WT DCM
BW (g) 12.860.9 13.360.6 21.460.6 21.760.8 23.261.0 22.760.7
N 8 8 18 13 11 16
ECG recording (anesthetized)
HR (bpm) 355627 430625*
,a 392618 394637 ND ND
PR (ms) 35613 3 613 8 623 8 62N D N D
QRS (ms) 9.660.3 10.360.3 11.060.3 16.760.6* ND ND
QT (ms) 34614 2 62* 36615 3 61* ND ND
N 66 66 - -
ECG recording (conscious)
HR (bpm) 740616 773615 721610 700667 2 6 696 9 8 617
PR (ms) 29.160.9 29.660.8 33.660.7 33.061.1 34.760.8 33.861.6
QRS (ms) 9.960.4 12.360.4 10.160.4 15.960.9** 10.160.1 16.961.4**
QT (ms) 17.160.4 23.360.9** 17.060.5 33.861.9** 18.560.6 37.962.2**
N 56 56 55
Data are means 6 SEM.
*P,0.05,
**P,0.01 vs. WT. BW: body weight. ND: not determined.
a: The significant difference from WT mice is probably due to a difference in depth of anesthesia.
doi:10.1371/journal.pone.0035353.t001
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PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e35353Figure 2. AP signals and force records obtained from WT and DCM LV at 2 months. A. Typical images of the endocardial surface of live LV
muscle from a WT mouse. Left: The LV muscle wall observed from the endocardial side using a 46objective. Six images were combined to produce
the full image. Right: Image of cardiac surface muscle cells (2566512 pixels, 1606320 mm area) observed with a 206 objective. Action potential
signals shown in B and E were obtained from this size of area. B. Representative AP signals recorded from the LVs of WT (top) and DCM (middle and
bottom) mice stimulated at 0.5 Hz. AP signals were obtained from middle region as 8616 pixel images at 3.67 ms intervals. Arrowheads indicate field
stimulation. Experiments were carried out at 25–27uC. C. Representative traces showing force development in LV papillary muscle from a WT (left)
and DCM (right) mouse during 0.5 Hz field stimulation (a) and during and after 3 Hz field stimulation (b). D. Average frequency of spontaneous
contractions after 3 Hz field stimulation in LV and RV. Means 6 SEM. (WT, n=10; DCM, n=14). E. Representative AP signals from the basal and apical
regions of endocardial surface (see Panel A) of a LV stimulated at 0.5 Hz. F. Comparison of APD50 values in the basal and apical regions of LVs and
center region of RVs from WT (LV: base, n=41; apex, n=41 from 10 hearts, RV center region: n=18 from 4 hearts,) and DCM (base, n=85; apex, n=64
from 14 hearts, RV: n=35 from 7 hearts). Means 6 SEM. **P,0.01 between WT and DCM. {P,0.05 between base and apex in LV.
doi:10.1371/journal.pone.0035353.g002
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was previously reported [27]. We therefore explored the DCM-
associated alterations in each component: the transient outward
K
+-current (Ito), the ultrarapid delayed rectifier K
+-current (IKur),
and the slowly-activating sustained K
+-current (Iss). The Iss in
DCM cells (isolated as the steady-state whole-cell current at pulse
end) had a smaller but comparable (,90%) amplitude to WT cells
(Fig. 3B-c); however, the Ito and IKur in DCM cells (see Method S1
for their isolation) had substantially smaller peak amplitudes than
WT cells (,30%) (Fig. 3C). Therefore, the smaller amplitude of
the outward whole-cell current can be attributed to the reduction
of Ito and IKur in DCM cells.
Gene expression and Western blot analyses in LV
Since the above results revealed a functional decrease in ionic
channel activities carrying Ito and IKur, we analyzed the expression
levels of the genes encoding the various ion channels that carry Ito
(Kv4.2), IK1 (Kir2.1 and Kir2.2), Iss (Kv2.1) and IKur (Kv1.5) [28–
29]. The genes encoding the accessory subunit KChIP2, which
contributes to Ito, and the homeodomain transcription factor Irx5,
which negatively regulates expression of Kv4.2 were also
determined [30–31]. In addition, Kir3.1 (KACh channel), Nav1.5
(voltage-gated Na
+ channel), Cav1.2 (L-type Ca
2+ channel),
Cav3.1 (T-type Ca
2+ channel) and NCX1 (Na
+-Ca
2+ exchanger)
were determined because they also may affect resting membrane
potential and AP configuration [28–29,32–34].
In DCM LVs, the expression levels of Kv4.2, KChIP2, Kv1.5
and Kir3.1 mRNAs were significantly diminished to about half or
less of those in WT LVs (Fig. 4A). Conversely, the expression levels
of Irx5 and Cav3.1 were increased 2-fold or more in DCM LVs
(Fig. 4A and B). The increase in Irx5 is consistent with the down-
regulation of Kv4.2 [31]. The expression levels of Kir2.1 and
Figure 3. DCM-associated alterations in AP waveform and membrane currents. A: APs of whole-cell clamped WT and DCM cells (a), evoked
at 5 Hz. The APD50 and APD80 (b) of WT (n=16) and DCM cells (n=12) were measured at repolarization to 218 and 258 mV, respectively. B: Records
of whole-cell current from WT and DCM cells (a), activated by voltage-steps (1 s to 2118 - +52 mV in 10 mV increment) from a holding potential of
278 mV. I–V relations of IK1 (b) and Iss (c) in DCM (n=10 or 8) and WT cells (n=12) were measured as the steady-state amplitude of the whole-cell
current at pulse end. C: Ito (a) and IKur (b) of WT and DCM cells, isolated using 100 mM-4AP and an inactivation prepulse (See Method S1). The records
were acquired with depolarizing pulses to +52, +32, +12, and to 28 mV. Insets expand the peaks in a faster time-base. I–V relations of Ito (c) and IKur
(d) compile their peak amplitudes in DCM (n=8) and WT cells (n=12 or 11). Dotted lines: zero-voltage or zero-current level. Data are means 6 SEM.
*p,0.05 between WT and DCM. Fig. 3B-a: Cm=139 (WT) and 152 pF (DCM).
doi:10.1371/journal.pone.0035353.g003
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difference was not significant. There was no significant difference
in the expression level of Kv2.1, Cav1.2, Nav1.5 or NCX1
between WT and DCM LVs. There were also no significant
changes in expression of Kir6.1 and Kir6.2, KATP channels (data
not shown).
Expression of channel proteins, for which mRNA was decreased
by two-fold or more, was verified by Western blot analysis. In
addition, protein levels of Cav1.2 and NCX1, which are abundant
in cardiac muscle and showed negligible change in mRNA level in
DCM, were also determined. Fig. 5 shows typical data and
comparison of the averaged values of each protein level. Kv4.2
and KChIP2 were significantly decreased in DCM LV to less than
50% of values in the WT. Kv1.5 was also significantly decreased to
65% of WT. There was no significant difference in Kir3.1 between
WT and DCM in spite of the significant difference in mRNA level.
This is consistent with no significant change in KAch currents
determined in isolated single myocytes (data not shown). There
were also no significant differences in expression levels for Cav1.2
and NCX1 between WT and DCM groups. In summary, the
decreases in Kv4.2, KChIP2 and Kv1.5 were significant in DCM
and well explain the changes in Ito and IKur.
Gene expression analysis in RV
Gene expression was also examined in RV because they
showed much less spontaneous activity than LV. Fig. 6
compares the expression levels of genes in which significant
differences were detected between WT and DCM LVs (Fig. 4).
In WT the level of Kv4.2 was 2-fold higher in RV than in LV,
whereas 5-fold more abundant in DCM. Therefore, in DCM,
the absolute amount of Kv4.2 mRNA in RV was not as low as
that in LV. In addition, the decrements in KChIP2 was less
marked in RVs than LVs. The expression levels of Kv1.5, Irx5
and Cav3.1 were similarly changed in DCM LV and RV. Thus
t h eh i g h e re x p r e s s i o no ft h eK v 4 .2 and its accessory subunit,
which is due to intrinsic property of RV and lesser down-
regulation, may account for the shorter APD and less
automaticity in DCM RV.
Comparison of automaticity, APD50 and mRNA
expression between 1-, 2- and 3-months old mice
Kaplan-Meier survival curves in Fig. 1A for these DCM model
mice show that over 90% of the animals survive the first month.
After 40 days, the survival rate decreases (also see [14]). The
symptoms of HF emerge around 3 months (Fig. 1). To explore the
changes occurring in DCM hearts during the 3 months after birth,
functional parameters and expression levels of affected ion channel
genes were determined. In DCM LVs from 1-month mice,
spontaneous activity was detected, but its frequency was obviously
lessthan at2 months(Fig.7A). IntheWT LV,therewereonlysmall
differences in APD50 values between 1- and 2-month mice (Fig. 7B).
By contrast, APD50 in the DCM LV markedly increased from 1 to 2
months. The increments were more prominent at 3 months.
To determine which ion channels contribute to the age-
dependent changes in automaticity and APD50 seen in DCM
mice, we analyzed the expression levels of genes in which
significant differences were detected between WT and DCM mice
at 2 months (Fig. 7C). In LVs from 1-month DCM mice, the level
of Kv4.2 expression was about 60% of that in WT mice and
declined further to about 25% of WT at 2 months and later.
Interestingly, Kv4.2 in the ventricle of the DCM neonate was
already significantly decreased to 7264% of the WT neonate
(n=6 for each). The levels of Kv1.5 and KChIP2 expression in
DCM mice were similar to those in WT mice at 1 month, but they
were significantly reduced at 2 months and later. In contrast, there
were no significant differences in Cav1.2 and Nav1.5 between WT
and DCM at 1–3 months. The expression of Cav3.1 was
consistently higher in DCM mice than WT mice at 1 to 3
months. For NCX1, there was no difference between WT and
DCM at 1 and 2 months, although it tended to increase at 3
months but without significant difference. The level of Irx5 in
DCM was highest at 1 month and gradually decreased to the level
of WT at 3 months, suggesting that some factor other than Irx5
may regulate the transcription of Kv4.2 in older DCM mice. In
summary, among gene expression of molecules determined in this
study, significant changes in Kv4.2, Irx5 and Cav3.1 started at 1
month or before, whereas changes in Kv1.5 and KChIP2 started
at around 2 months.
Discussion
In this study, we investigated how electrical remodeling and HF
proceed in a knock-in mouse model of inherited DCM, in which
myofibrillar Ca
2+ sensitivity was intrinsically reduced [3,14,35].
This study indicates that progressive, multiple and qualitatively
different types of electrical remodeling develop in DCM hearts
prior to symptoms of HF.
Figure 4. Relative expression levels of mRNA encoding the
indicated ion channels and auxiliary subunits in LVs. Quantita-
tive real-time PCR analysis was carried out with LVs of 2-month WT
(n=7) and DCM mice (n=7). GAPDH gene was used as an internal
control. Data from individual samples were normalized to the average
of WT mice. A. Voltage-dependent K
+ channels, inwardly rectifying K
+
channels and related proteins. B. Voltage-dependent Na
+ channels,
Ca
2+ channels and Na
+-Ca
2+ exchanger. Plots are means 6 SEM (n=7).
**P,0.01, *P,0.05 between WT and DCM.
doi:10.1371/journal.pone.0035353.g004
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model
There are at least 3 stages in terms of development of HF and
electrical remodeling in this DCM model. In stage 1, which is
represented by DCM mice at 1 month, mortality was low with no
clear symptoms of HF in spite of enlarged hearts. Slight
prolongation of APD50 and moderate increase in spontaneous
activity were detected in the myocardium. Gene expression of
Kv4.2 was significantly lower than WT. Because the decrease in
Figure 5. Western blot analysis of major channel proteins in LV. The membrane protein samples (50 mg protein for each) from 2-month WT
(n=4) and DCM LVs (n=5) were separated by SDS-PAGE and Western blot analysis was carried out. See Methods for detail. A. Representative
immunoblots of individual experiments. B. Averaged expression levels. The relative expression levels for each protein were normalized to the average
value for the WT. Data are means 6 SEM (WT: n=4, DCM: n=5). **P,0.01 between WT and DCM.
doi:10.1371/journal.pone.0035353.g005
Figure 6. Comparison of mRNA expression between LV and RV. The expression levels of each gene are expressed relative to the average of
WT LV. Data from LV are the same as in Figure 4. (n=7 for each). **P,0.01, *P,0.05 between WT and DCM. {P,0.05 between LV and RV.
doi:10.1371/journal.pone.0035353.g006
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neonates, these changes seem to occur during embryonic
development. By contrast to Kv4.2, down-regulation of Kv1.5 or
KChIP2 was not observed. The DCM model mice, at 1 month or
before, are relatively safe with only modest electrical remodeling
and no congestive HF.
In stage 2, which is represented by DCM mice at 2 months, they
displayed high mortality without clear symptoms of HF. Their
myocardium showed much more frequent spontaneous activity
and further prolonged APD50 with an increased spatial difference
compared to 1-month mice. These changes are associated with a
reduction in K
+ current density (Ito, IKur), which arises from
substantial decreases in expression of Kv4.2, Kv1.5 and KChIP2,
and may be related to the SD at around 2 months. Because
knockdown of Kv4.2, or Kv1.5 alone does not result in SD or HF
[36–37], combined decreases in Kv4.2, Kv1.5 and KChIP2 may
play an important role in the frequent premature SD in DCM
mice. As HF starts to develop after this stage, the DCM hearts at 2
Figure 7. Spontaneous activities, APD50 and mRNA expression in LV from 1-, 2- and 3-month WT and DCM mice. A. Frequencies of
spontaneous contractions after 3 Hz field stimulation in normal Krebs solution. (n=9–14) B. APD50 values in LVs from mice at 1, 2 and 3 months (data
are averages of 7–14 hearts). #n: WT;Nm: DCM. C. Comparison of mRNA expression in LVs at 1- (n=5) 2- (n=7) and 3-months (n=7). The
expression levels of each gene are expressed relative to the average in WT LV at 2 month. Data are means 6 SEM. *P,0.05, **P,0.01 between WT
and DCM at the same age.
doi:10.1371/journal.pone.0035353.g007
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increased electrophysiological vulnerability due to the remodeling
of these ion channels.
In stage 3, represented by DCM mice at 3 months, DCM hearts
enlarge further as many of them enter the true HF stage associated
with lung edema. Expression levels of Kv4.2, Kv1.5 and KChIP2
are further decreased and APD50 is further prolonged. The
expression of NCX1 tends to increase but without significant
difference. Mice at this age may die with variable pathologies
including lethal arrhythmias, which are related to severe HF.
The above time-course demonstrate that electrical remodeling
precedes HF in this mouse model of human DCM mutation of the
TNTT2 gene. This time-course is consistent with the observations
in human patients in which SD often occurs before awareness of
the disease [2,18]. In the human, however, onset and severity of
symptoms are much more variable presumably due to various
genetic and environmental factors. Detailed analysis using this
animal model can help to reveal the time course of symptoms and
electrical remodeling in this inherited DCM.
Causes for prolongation of APD, spontaneous activity
and arrhythmias
Our measurements showed that DCM cells at 2 months had a
broader AP overshoot than WT cells. Among the three major
repolarizing current components in mouse ventricular cells, Ito,
IKur, and Iss [27], a prominent reduction was observed for Ito and
IKur, while Iss was maintained at a comparable amplitude in DCM
cells. In support of this, molecular correlates of Ito and IKur had a
reduced expression in DCM cells at both mRNA and protein
levels. Furthermore, these changes were less pronounced in RV at
2 months and LV in 1 month mice. These findings indicate that
the prolonged APD in DCM cells is mostly attributable to the
reduction of Ito and IKur.
The reduction of Ito and IKur in DCM cells, on the other hand,
leads to a reduced repolarization reserve [38]. Since these current
components are activated in the depolarized voltage-range (above
240 mV), their reduction in DCM cells would lead to a narrower
margin for the occurrence EAD, thus providing an arrhythmo-
genic substrate. This notion is consistent with the actual
occurrence of EAD in DCM cells (Fig. 2B).
The DAD was also observed in DCM cells. The prolongation of
the APD may increase Ca
2+ influx, enhance the Ca
2+-extruding
NCX reaction that provide more inward current, and cause
depolarization at later stages of repolarization [39–40]. The b-
adrenergic/cAMP system must also be considered as a source of
DAD in DCM mice. This potentially causes an increased
automaticity, especially in situ, by increasing the cAMP level to
enhance phosphorylation of phospholamban and RyR2 and/or
activate If currents [20,41–43]. Sympathetic tone has been
reported to be elevated in these animals to maintain sufficient
cardiac output whereas vagal activity is decreased [14,20–21].
Consistently, more frequent arrhythmias were observed in DCM
mice under mild restraint condition. Up-regulation of Cav3.1
raises a possible contribution of T-type Ca
2+ currents in the
development of myocardial automaticity in DCM mice, although
our results showed no clear functional correlation. To summarize,
the increased DAD and EAD may well explain the occurrence of
premature ventricular complex (PVC) (Fig. 1) and ventricular
tachycardia [14].
In addition to the increased spontaneous activity, myocardial
fibrosis, which has been observed in 2 month mice[14,44], and an
increased spatial difference in APD (Fig. 2F) may also have some
additional contribution to the lethal arrhythmias [45–46]. Both
factors by themselves cannot cause spontaneous activity or PVC
after T wave. However, myocardial fibrosis may contribute to
sustain arrhythmia by a re-entry mechanism when re-entrant
activity comes back at the repolarizing phase of action potential
(R-on-T phenomenon). Also fibrosis and the increased spatial
difference can facilitate dispersion of repolarization and T wave
alternans [46] to worsen Torsades de pointes. Probably these
factors in addition to the ion channel remodeling combine in
development of severe arrhythmia. Further studies are required to
elucidate the detailed developmental mechanisms leading to lethal
arrhythmia in DCM.
Comparison with other HF and DCM models
It is well known that HF and its preceding hypertrophic stage
are also associated with electrical remodeling [39,47–49].
Probably the electrical remodeling in this DCM model is, in part,
related to those in HF [14]; however, there are distinctions. The
most common ion channel remodeling in failing heart is reduction
in Ito and Kv4.2 transcription along with APD prolongation
[10,39,47], and concurrent up-regulation of NCX1 [39,47–49].
Changes in other K current components, including Kv1.5 and
KChIP2, have been reported in some but not all cases [11,39,47].
In our DCM model, a decrease in Kv4.2 is already observed in
neonates when HF is not evident. In contrast, a significant increase
in NCX1 was not detected at 2 months. The time course and
underlying mechanisms of electrical remodeling are not the same
among the various types of HF and remain to be elucidated for
each HF model.
Probably the mutation in TNNT2 is not directly and specifically
responsible for the arrhythmia because similar lethal arrhythmias
are also frequently found in DCM patients with gene mutations of
other proteins [1–4]. The DCM heart presumably undergoes a
complex series of changes in neurohumoral mechanisms such as
the sympathetic nervous (SNS) and renin–angiotensin–aldosterone
systems (RAAS) to compensate for the reduction in cardiac
contractility [39]. These mechanisms are likely to affect cardiac
gene expression resulting in the electrical remodeling. Interesting-
ly, among mouse models that develop characteristics of DCM, an
electrical remodeling similar to our model has been reported in the
transgenic mouse model of a1B-adrenergic receptor overexpression
(a1B-AR mice), in which a phenotype mimics idiopathic DCM and
results in HF and/or death with arrhythmia [11]. In this a1B-AR
mouse model, the down-regulation of Kv4.2, Kv1.5 and KChIP2
was evident at a young age (2–3 months) before development of
HF (9–12 months), although onset-timing of those changes is
unclear. The similarity between their and our model raises an
interesting possibility that activation of the SNS involving a1B-AR
system is related to the remodeling in our DK210 mice. The next
step will be to clarify what kinds of factors cause the multiple types
electrical remodeling. At least three major factors may involve
these multistep remodeling.
Conclusions
Our results indicate that multiple types of progressive electrical
remodeling occur at different time points in the hearts of DCM
model mice, and that combined electrical remodeling in DCM
model mice prolongs APD and increases the excitability of
ventricular myocytes, which can develop ventricular arrhythmia.
To increase our understandings of the mechanisms of SD in
inherited DCM in general, further studies with other knock-in
models are absolutely required. Because the DCM mice survive
relatively well while the extent of electrical remodeling remains
small, early initiation of therapy to suppress remodeling may be a
key to prevent SD in inherited DCM.
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Animal model
All experiments were carried out in accordance with the Ethics
Committee guidelines and were approved by the Committee for
Animal Experimentation of Juntendo University (approval num-
ber 230021) and by Saga University Animal Care and Use
Committee. The investigation conforms to Guiding Principles for the
Care and Use of Animals in the Field of Physiological Sciences
(Physiological Society of Japan).
A knock-in mouse with deletion mutation, Lys-210, in its
endogenous cardiac troponin T gene (Tnnt2 DK210) was used as
the DCM model animal [14]. These mice had been backcrossed to
the C57BL/6J line for at least 10 generations and were maintained
under specific pathogen-free (SPF) conditions. Mixed-gender
homozygous mutant and wild type (WT) mice were obtained by
crossing heterozygous mutant mice and were used as DCM and
non-DCM models, respectively.
Electrocardiography
Electrocardiography (ECG) lead II was recorded from mice
anesthetized with an intraperitoneal injection (i.p.) of pentobarbi-
tal (20–25 mg/kg) using ECG Amplifier (Nihon Koden, Japan).
ECG records of conscious mice were obtained with ECGenie
(Mouse Specifics, Inc. MA, USA), which took signals noninvasively
from palms and planters of animals using footplate electrodes. To
determine RR, QRS and QT intervals, ECG signals were
recorded for 2 min for each mouse. To detect arrhythmia in
mice, they were placed on the footplate electrodes for 30 min in an
oval plastic dome with openings at mouth and tail (7 cm length,
4 cm width, and 4 cm height) to restrict free movement. This
procedure gave mice mild restraint stress to increase frequency of
arrhythmias and allowed us to analyze many mice repeatedly.
Records were analyzed with ECG Analysis software (AD
Instruments, Japan).
Determination of wheel running activity
To estimate the extent of heart failure of DCM mice, physical
activity was evaluated by measuring voluntary wheel running
activity [22] (paper in preparation). WT and DCM mice at 6
weeks or later were housed with free access to a running wheel
(6 cm radius, Mini Mitter Co. Inc. OR, USA) for two days a week
and their running activities were measured (round/day). Running
activities at 2 and 3 months were determined from the same
animals.
Solutions and reagents used in experiments with
myocardium
Normal Krebs solution for myocardium experiments contained
(mM): 120 NaCl, 5 KCl, 25 NaHCO3, 1 NaH2PO4, 2 CaCl2,1
MgCl2, 10 glucose and was saturated with 95% O2-5% CO2.
High-K
+ Krebs solution used for muscle preparation contained
25 mM KCl instead of 5 mM. Di-4-ANEPPS was obtained from
Invitrogen/Molecular Probes (Eugene, OR, USA).
Experiments with isolated myocardium
Mice at 1, 2 and 3 months of age were deeply anesthetized with
pentobarbital sodium (100 mg/kg i.p.) and heparin (100 unit/kg).
The hearts and lungs were excised, rinsed in Krebs solution and
their weights measured. The hearts were perfused via the aorta
with a high-K
+ Krebs solution. Muscles of the left ventricles (LV)
were dissected in high K
+ solution and then kept in normal Krebs
solution at room temperature. Measurements were made 1 to 3 h
after preparation.
Membrane potential imaging experiments were carried out as
described previously with some modification [23,50–51]. LV
muscles were loaded with 25 mM di-4-ANEPPS for 20 min, after
which they were mounted in a chamber on the stage of an inverted
microscope equipped with the Nipkow disc confocal system
(CSU22, Yokogawa, Japan) and a W-view system (Model 8509,
Hamamatsu Photonics, Hamamatsu, Japan). Di-4-ANEPPS was
excited by 488 nm laser light and fluorescence images at 525 and
620 nm were simultaneously captured, side-by-side, using the
same camera, and ratio images were then calculated. To
determine the optical AP duration (APD), membrane potential
signals were obtained at 3.67 ms intervals as 16632 pixel signals
(binning=16616) from 1606320 mm areas. The APD50 (i.e., the
time at which the down-stroke of the AP had recovered 50%
toward baseline) was obtained as the activation minus the
repolarization time points. To monitor AP signals for longer
periods, 2-dimensional images were obtained at 8.7 ms intervals
(646128 pixels with binning=262). Experiments were carried out
at 25,27uC.
To detect spontaneous activity of myocardium, isometric
contractions were also determined. Papillary muscles were isolated
from the LV (0.5–1.0 mm in diameter) and mounted horizontally,
using silk thread, between a force transducer and a fixed hook in a
chamber. They were perfused with Krebs solution at 30uCa ta
rate of 2 ml/min and electrically field-stimulated at 0.5 or 3 Hz
using a suprathreshold voltage. To evaluate automaticity,
spontaneous contractions were recorded for 1 min in the absence
of stimulation following conditioning pulses applied at 3 Hz for
15 min.
Whole-cell clamp recording
Single heart cells were isolated from left ventricles of mice using
an established enzymatic method [52]. The mice were killed by an
overdose injection of pentobarbital sodium (300 mg/kg, i.p.). After
isolation, the cells were whole-cell clamped in the current- or
voltage-clamp mode using a patch-clamp amplifier (CEZ-2300,
Nihon Koden). Patch-pipettes (2–3 MV) were pulled from thin-
wall glass capillaries (14-084-12, Hilgenberg), and series resistance
(3–5 MV) was compensated by 50–70% electronically. Data
acquisition and analysis were done using pClamp 10 software suit
and a DigiData 1440A signal interface (Molecular Devices). All
voltage data were corrected for a liquid junction potential of
28 mV assumed at the pipette tip.
Whole-cell clamp records were acquired at 37uC. For recording
APs, the cells were stimulated at 5 Hz by injecting 5 ms supra-
threshold current pulses via the patch-pipette. They were
superfused with Tyrode solution containing (mM): 140 NaCl,
5.4 KCl, 1.8 CaCl2, 0.5 MgCl2, 0.33 NaH2PO4, 11 glucose, and 5
HEPES-NaOH (pH 7.4). Pipette solution contained (mM): 110 K-
aspartate, 30 KCl, 10 NaCl, 5 Mg-ATP, 0.1 Tris-GTP, and 20
HEPES-KOH (pH 7.2). For recording the membrane current, 1 s
command pulses were applied to the cells every 4 s from a holding
potential of 278 mV. To eliminate L-type Ca-current and [Ca]i-
activated currents, Tyrode solution was modified to contain
0.1 mM CdCl2, as well as the pipette solution to contain 4 mM
BAPTA and no NaCl. Detailed procedures for separation of Ito,
and IKur are described in Method S1.
Real-time RT-PCR
Total RNA was isolated from the LV using an RNeasy Fibrous
Tissue Mini Kit (Qiagen) and treated with DNase I to prevent
contamination with genomic DNA. First strand cDNA was
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(Applied Biosystems). The expression of genes encoding Kv1.5,
Kv2.1, Kv4.2, Kir2.1, Kir2.2, Irx5, KChIP2, Nav1.5, Cav1.2,
Cav3.1 and NCX1 was assessed using quantitative real-time PCR
analysis. The oligonucleotide primers used for the real-time PCR
are listed in Table S1. PCR was carried out using ABI PRISM
7500 Real Time PCR Systems. The cycling protocol included an
initial stage at 95uC for 10 min, followed by 40 cycles at 95uC for
15 s and 60uC for 1 min. To ensure the validity of the result, the
linearity and the efficiency criteria (slope of 23.1 to 23.6 in the Ct
vs log-template amount) were carefully followed. The mRNA
expression level of each gene in each sample was quantified
relative to that of the Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) gene in the same sample. For each gene, data from
individual samples were normalized to the average values from LV
of 2-month-old WT mice.
Western blot analysis
Western blotting was carried out with membrane protein
samples. Briefly, LVs (10–20 mg) were dissected from WT and
DCM mice and homogenized in a buffer containing 0.3 M
sucrose, 20 mM MOPS, pH 7.4 and a cocktail of protease
inhibitor (aprotinin, antipain, chymostatin, leupeptin, and pep-
statin A at 2 mg/ml each). The homogenate was centrifuged for
10 min at 2,000 g to remove contractile proteins and insoluble
materials. The supernatant was centrifuged for 20 min at
100,000 g to sediment the membrane fractions. The resultant
pellet was washed twice with the buffer and resuspended in a small
volume (50 ml) of the buffer. Protein concentrations were
determined by Advanced protein assay kit (Cytoskeleton Inc.).
The protein samples (50 mg protein for each) were separated by
SDS-PAGE with a 3–15% gradient gel and then transferred onto
a polyvinylidene fluoride membrane. The membrane was blocked
with 5% nonfat dry milk powder in TBS (150 mM NaCl, 20 mM
Tris-Cl, pH 7.5) containing 0.05% Tween 20 (TTBS) for 1 h at
room temperature and probed with primary antibodies overnight
at 4uC. The antibodies used are: rabbit polyclonal anti-Kv4.2
(Alomone labs, APC-023), mouse monoclonal anti-KChIP2 (UC
Davis/NIH NeuroMab Facility, clone K60/73), goat polyclonal
anti-Kv1.5 (Santa Cruz Biotechnology, sc-11679), rabbit poly-
clonal anti-Cav1.2 (Alomone labs, ACC-003), mouse monoclonal
anti-NCX1 (Abcam, ab6495), and mouse monoclonal anti-b-actin
(Abcam, ab8226). After three washings with TTBS, the membrane
was then probed with horseradish peroxidase-conjugated second-
ary antibodies for 2 h at room temperature. After extensive
washings with TTBS, the positive bands were detected by
LAS3000 lumino image analyzer (Fujifilm, Japan) using Immu-
noStar LD chemiluminescence detection reagents (Wako Pure
Chemical Industries). For polyclonal antibodies, validations of the
specific bands were confirmed with the antigen peptides provided
by the manufacturers. The densities of specific bands were
determined using MultiGauge software (Fujifilm, Japan) and
corrected for the density of b-actin.
Statistics
Data are presented as means 6 SEM. Statistical comparisons
have been made using GraphPad Prism5 Software (USA).
Student’s t-test was used to compare means of two groups. P
values,0.05 were considered significant.
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